PROCEPT BioRobotics Corp
PRCTNasdaq
$19.22
↑ +0.1%Jul 17 close · end-of-day
Price
1Y↓ -66.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.1B
Enterprise Value
$892.2M
P/E
—
P/S
3.4
P/B
3.1
EV/EBITDA
—
PEG
—
FCF Yield
-7.4%
Dividend Yield
—
Revenue (TTM)
$322.0M
Net Income (TTM)
-$7.0M
Free Cash Flow (TTM)
-$80.6M
Gross Margin
64.0%
Operating Margin
-33.9%
Net Margin
-2.2%
ROE
-2.0%
ROIC
-56.0%
Debt / Equity
0.1
Net Cash
$194.0M
Return 1Y
-67.4%
Company profile
PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery.
- CEO
- Reza Zadno
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 430
- Headquarters
- California
- Website
- procept-biorobotics.com
Management & directors
- Nouri AlalehEVP, CLO, CORP. SEC.
- Templin Barry LEVP, Chief Technology Officer
- Waters KevinEVP, CFO
- Wood Larry LPresident, CEO
Roles derived from SEC Form 4 filings.
Earnings
PRCT Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$83.1M↑ +20.2%
Diluted EPS-$0.56↑ +24.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $34.5M | $75.0M | $136.2M | $224.5M | $308.1M |
| Gross profit | -$1.3M | $15.9M | $37.1M | $71.0M | $137.1M | $196.2M |
| Operating income | -$47.8M | -$54.2M | -$80.7M | -$109.2M | -$96.6M | -$103.9M |
| Net income | -$53.0M | -$59,853.00 | -$87,154.00 | -$105,897.00 | -$91,413.00 | -$95,572.00 |
| Diluted EPS | -$14.47 | -$3.63 | -$1.96 | -$2.24 | -$1.75 | -$1.72 |
| Operating cash flow | -$48.3M | -$57.3M | -$80.4M | -$108.0M | -$99.2M | -$49.0M |
| Free cash flow | -$48.6M | -$57.9M | -$83.0M | -$133.2M | -$103.6M | -$58.3M |
| Gross margin | -16.3% | 46.0% | 49.4% | 52.2% | 61.1% | 63.7% |
| Operating margin | -619.4% | -157.1% | -107.6% | -80.2% | -43.0% | -33.7% |
| Net margin | -687.0% | -0.2% | -0.1% | -0.1% | -0.0% | -0.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $53.4M | $58.4M | $68.2M | $69.2M | $79.2M | $83.3M | $76.4M | $83.1M |
| Gross profit | $31.5M | $36.9M | $43.7M | $44.2M | $51.7M | $54.0M | $46.3M | $53.9M |
| Operating income | -$26.8M | -$22.4M | -$19.7M | -$27.4M | -$22.2M | -$23.2M | -$31.0M | -$32.6M |
| Net income | -$25.6M | -$21.0M | $72.5M | -$24.7M | -$19.6M | -$21.4M | $65.6M | -$31.6M |
| Diluted EPS | -$0.50 | -$0.40 | -$0.34 | -$0.45 | -$0.35 | -$0.38 | -$0.54 | -$0.56 |
| Operating cash flow | -$15.7M | -$18.8M | -$32.4M | -$17.0M | -$15.0M | -$6.6M | -$10.3M | -$38.1M |
| Free cash flow | -$16.8M | -$19.0M | -$33.6M | -$18.8M | -$17.8M | -$9.5M | -$12.2M | -$41.0M |
| Gross margin | 59.0% | 63.2% | 64.0% | 63.9% | 65.4% | 64.8% | 60.6% | 64.9% |
| Operating margin | -50.3% | -38.4% | -28.9% | -39.7% | -28.0% | -27.8% | -40.6% | -39.2% |
| Net margin | -48.0% | -35.9% | 106.2% | -35.8% | -24.7% | -25.7% | 85.9% | -38.1% |
Company news
Jul 15, 2026
Jun 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-09 | Desai Antal Rohit | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | Dodrill Amy M. | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | Garrett Mary | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | Harris Taylor C. | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | Sandoval Elisabeth | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | MOLL FREDERIC H | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | PRESCOTT THOMAS M | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-09 | PUCKETT DAN | Award | 3,315 | $0.00 | $0.00 | filing |
| 2026-06-08 | Templin Barry L· EVP, Chief Technology Officer | Sale | 358 | $28.48 | $10,195.48 | filing |
| 2026-06-08 | Waters Kevin· EVP, CFO | Sale | 357 | $28.48 | $10,167.00 | filing |
| 2026-06-08 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 285 | $28.48 | $8,116.52 | filing |
| 2026-03-19 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 3,031 | $25.82 | $78,258.30 | filing |
| 2026-03-19 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 2,332 | $26.15 | $60,972.47 | filing |
| 2026-03-17 | Waters Kevin· EVP, CFO | Sale | 706 | $28.15 | $19,876.16 | filing |
| 2026-03-17 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 304 | $28.15 | $8,558.57 | filing |
| 2026-03-10 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 3,098 | $25.60 | $79,320.26 | filing |
| 2026-03-10 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 145 | $26.74 | $3,877.00 | filing |
| 2026-03-09 | Desai Antal Rohit | Buy | 53,818 | $24.91 | $1.3M | filing |
| 2026-03-09 | Desai Antal Rohit | Buy | 43,581 | $24.08 | $1.0M | filing |
| 2026-03-09 | Desai Antal Rohit | Buy | 1,300 | $25.42 | $33,042.49 | filing |
| 2026-03-06 | Desai Antal Rohit | Buy | 106,554 | $23.33 | $2.5M | filing |
| 2026-03-06 | Desai Antal Rohit | Buy | 53,763 | $24.10 | $1.3M | filing |
| 2026-03-06 | Nouri Alaleh· EVP, CLO, CORP. SEC. | Sale | 6,892 | $23.70 | $163,353.49 | filing |
| 2026-03-06 | Waters Kevin· EVP, CFO | Sale | 6,721 | $23.70 | $159,300.47 | filing |
| 2026-03-05 | Desai Antal Rohit | Buy | 142,498 | $25.44 | $3.6M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.